BOSTON, June 20,
2024 /PRNewswire/ -- Glytec, a leading diabetes
and insulin management software company, proudly announces a
strategic partnership with Major Health Partners (MHP), a renowned
community-based hospital in Shelbyville,
IN. This collaboration signifies a pivotal step forward in
advancing diabetes care and underscores the shared dedication of
both organizations to elevate patient safety and outcomes, cost of
quality care, and the healthcare experience.
Glytec's Innovations in Diabetes and Insulin
Management
"The partnership between Glytec and Major Health
Partners is a testament to our ongoing commitment to innovation and
excellence in diabetes and insulin management," says Patrick Cua, Chief Executive Officer at Glytec.
"By integrating Glytec's FDA-cleared Glucommanderâ„¢ software, MHP
aims to standardize insulin titration, reduce risks of severe
hypoglycemia, and further its mission towards zero harm and
cost-effective quality care."
"We are excited to implement Glytec's best-in-class solution for
diabetes and insulin management," states Jordan Messler, Chief Medical Officer at Glytec.
"This partnership not only signifies our dedication to advancing
patient safety and outcomes but also underscores our commitment to
growth and innovation within the healthcare industry while helping
hospitals improve clinician workflows and achieve
return-on-investment (ROI) on quality care solutions."
Glytec's program leads to reduced workflow and errors and a
reduced length of stay for patients resulting in increased
available ICU beds. The Glytec solution is backed by over 100
patents and 100 whitepapers and medical publications and empowers
hospitals and healthcare organizations with personalized insulin
dosing recommendations. With one-third of hospitalized patients
requiring insulin therapy, this collaboration is poised to drive
significant improvements in patient safety and outcomes.
MHP's Dedication to Patient-Centered, Collaborative
Healthcare
"We hold Glytec in high regard as the
best-in-class solution for insulin management within the hospital
setting," says Don Barton, CTO,
Major Health Partners. "We have a highly dedicated and enthusiastic
team led by our Chief Medical Officer, Dr. Paula Gustafson,
who are ready to implement the Glytec program."
Dr. Gustafson played a pivotal role in facilitating the
partnership with Glytec, which is merely the latest of Dr.
Gustafson's strides toward quality improvement. Her leadership was
also instrumental in the success of MHP's Cardio-Metabolic program,
which has garnered recognition from esteemed organizations such as
the Cardiometabolic Center Alliance and the Indiana State Board of
Health for its exceptional results.
MHP, renowned for its dedication to patient-centered healthcare,
is part of the Suburban Health Organization (SHO), a collaborative
effort of thirteen community-based Indiana hospitals. This partnership reflects
Glytec's ongoing commitment to collaborating with healthcare
leaders to advance the standard of care for patients nationwide and
addressing health inequities and social determinants of health to
benefit patients, providers, and payors in the US healthcare system
and systems abroad.
Preparing for the Future: Addressing CMS Mandates and the
TEAM Payment Model
As we face the proposed CMS mandates,
including the mandatory reporting of Severe Hypoglycemia and Severe
Hyperglycemia events, and the rollout of the TEAM Payment Model in
January 2026, it becomes even more
imperative for us to stand together and empower our partners with
the tools, insights, and support needed to navigate these changes
seamlessly.
About Glytec
Glytec's industry leading SaaS platform,
trusted by 350+ hospitals, empowers collaborative diabetes
management and insulin dosing, improving patient outcomes, reducing
length of stay, and streamlining workflows while delivering a 6-8x
ROI. The first-ever FDA-cleared cloud-based insulin management
software is EMR-integrated, easy to set up, and validated by over
100 patents and over 100 publications. The Glytec Glucommander®
solution, with clinical decision support, workflow alerts, patient
monitoring, at-risk patient identification, and AI-driven
analytics, is supported by a mission-driven team dedicated to
helping healthcare leaders, clinicians and patients promote health
equity and improve diabetes outcomes from hospital to home. We are
on a mission, join us.
For more information, follow Glytec on X (@Glytec)
and LinkedIn, or visit www.glytec.com.
About Major Health Partners (MHP)
Providing Friendly,
Patient-Centered Healthcare in Shelbyville, IN
Major Health Partners is a leading healthcare provider for
patients, not only in Shelby County,
Indiana but also from the southeastern part of the state.
Since 1924, Major Health Partners has grown to offer a wide
spectrum of services, leading the region in many areas of
healthcare delivery. We provide quality care through our unique
combination of state-of-the-art technology, modern facilities, and
personal service. We give you all the advantages found at large
urban hospitals, combined with genuine personal service.
MHP was accredited in Quality and Safety by the Accreditation
Commission for Health Care (ACHC) and Awarded the Top 100 Hospitals
by The Chartis Group in 2023.
MHP is also a proud partner of Suburban Health Organization
(SHO), which is comprised of thirteen community-based Indiana hospitals working together to improve
access to the highest quality healthcare possible. Incorporated in
1994, SHO serves its members by providing a collaborative forum to
facilitate desired integrations and outcomes, while allowing care
to remain local and preserving deep-rooted ties to hospital
communities. For nearly 30 years, this synergetic group has created
value by forming shared services, leveraging combined purchasing
power, sharing best practices, and founding innovative solutions to
some of healthcare's biggest challenges.
For more information, visit https://www.mymhp.org/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/glytec-and-major-health-partners-mhp-unite-to-empower-collaborative-diabetes-and-insulin-management-302177522.html
SOURCE Glytec